跳至主要内容
临床试验/IRCT20140107016123N14
IRCT20140107016123N14招募中未知

The effect of pomegranate extract tablet on some of metabolic factor, hepatokines (fetuin A, FGF21), inflammatory biomarkers, anthropometric indices and grade of fatty liver in patients with non-alcoholic fatty Liver disease

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age:18 to 65 years old
  • Body mass index 29.4 to 40
  • Presence of non-alcoholic steathepatitis in ultrasonography with degree of steatosis higher than grade 1
  • consent with collaboration in study
  • Not taking any dietary supplements
  • Not being on a special diet
  • the liver enzyme serum level (Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST)) 1.5 times greater than the highest normal up to a 5 times more than the highest level of normal range
  • non diabetes

排除标准

  • People with a history of hepatitis including A, B and C; Other liver diseases including autoimmune liver disease, liver transplantation, liver metabolic disease, Wilson's disease
  • gastrointestinal diseases
  • cardiovascular diseases
  • kidney diseases
  • endocrine disorders (such as hypothyroidism or hyperthyroidism, Cushing's)
  • having a history of drinking more than 10 grams per day in women and more than 20 grams per day in men
  • Taking any medicine, insulin, hepatic steatosis drugs
  • getting intravenous nutrition
  • getting special diets and taking vitamin supplements in the last three months
  • pregnancy or lactating
  • weight loss surgery during the last year
  • Unwillingness to cooperate

研究者

相似试验

The effect of pomegranate extract on non alcoholic... | 临床试验